Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_assertion type Assertion NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_head.
- NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_assertion wasGeneratedBy ECO_0000203 NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_provenance.
- NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_assertion wasDerivedFrom befree-20150227 NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_provenance.
- NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_assertion SIO_000772 24581742 NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_provenance.
- NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_assertion evidence source_evidence_literature NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_provenance.
- NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_assertion description "[These data provide treatment options for affected individuals and strongly suggest that investigation of GUCY1A3 and other members of the NO-sGC-cGMP pathway is warranted in both isolated early-onset achalasia and nonsyndromic moyamoya.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442002.RAZjAnvDHu_uw50LNUSJaayVzO-Mt6xGSwgUC2p06WNJs130_provenance.